Literature DB >> 8313815

Gastric mucosal toxicity of duodenal juice constituents in the rat. Acute studies using ex vivo rat gastric chamber model.

D Armstrong1, E R Rytina, G M Murphy, R H Dowling.   

Abstract

To determine the acute gastrotoxicity of refluxed duodenal contents, an ex vivo rat gastric chamber was used to study mucosal damage produced by conjugated and unconjugated human bile acids and lysolecithin at neutral and acidic pH; the effects of trypsin, human duodenal aspirate, and combinations of chenodeoxycholic acid, lecithin, and lysolecithin were also studied. At neutral pH, all bile acids except tauroursodeoxycholic acid, caused dose-dependent falls in mucosal potential difference and losses of mucosal nucleic acid into the chamber fluid, indicating mucosal damage. The di-alpha-hydroxy bile acids, deoxycholic and chenodeoxycholic acids, were more gastrotoxic than cholic and ursodeoxycholic acids, and all unconjugated bile acids were more toxic than their conjugated species, none of which produced damage at concentrations below 2.0 mM. For all but the taurine conjugates, bile acid-induced changes in potential difference were lower at acidic then at neutral pH. Lysolecithin gastrotoxicity, comparable at neutral pH to that of chenodeoxycholic acid, was also reduced at acidic pH. Lecithin decreased the gastrotoxicity of chenodeoxycholic acid and lysolecithin. Trypsin produced no damage, and the gastrotoxicity of human duodenal aspirate was unaffected by prior heat inactivation of pancreatic enzymes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8313815     DOI: 10.1007/bf02090205

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  39 in total

1.  Studies on lipid metabolism in the small intestine with observations on the role of bile salts.

Authors:  A M DAWSON; K J ISSELBACHER
Journal:  J Clin Invest       Date:  1960-05       Impact factor: 14.808

2.  Bile acids are not equally damaging to the gastric mucosa.

Authors:  J W Harmon; T Doong; T R Gadacz
Journal:  Surgery       Date:  1978-07       Impact factor: 3.982

3.  Role of mucus in the repair of gastric epithelial damage in the rat. Inhibition of epithelial recovery by mucolytic agents.

Authors:  J L Wallace; B J Whittle
Journal:  Gastroenterology       Date:  1986-09       Impact factor: 22.682

4.  A test for pyloric regurgitation.

Authors:  W M Capper; G R Airth; J O Kilby
Journal:  Lancet       Date:  1966-09-17       Impact factor: 79.321

5.  Mortality from gastric cancer following gastric surgery for peptic ulcer.

Authors:  C P Caygill; M J Hill; J S Kirkham; T C Northfield
Journal:  Lancet       Date:  1986-04-26       Impact factor: 79.321

6.  Safe use of ursodeoxycholic acid in the treatment of dyspeptic symptoms in patients with chronic active hepatitis: a double-blind controlled trial.

Authors:  C Del Vecchio Blanco; N Caporaso; S Gentile; M Rinaldi; R Pucci
Journal:  J Int Med Res       Date:  1982       Impact factor: 1.671

7.  Ursodeoxycholic acid treatment of bile reflux gastritis.

Authors:  A B Stefaniwsky; G S Tint; J Speck; S Shefer; G Salen
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

8.  Is the ex vivo rat gastric chamber model suitable for studying the gastrotoxicity of refluxed duodenal contents? Initial results using deoxycholic acid.

Authors:  D Armstrong; M Farrell; A Hanby; G M Murphy; R H Dowling
Journal:  Clin Chim Acta       Date:  1988-12-30       Impact factor: 3.786

9.  Effects of bile salts on amphibian gastric mucosa.

Authors:  W Silen; J G Forte
Journal:  Am J Physiol       Date:  1975-02

10.  Differing ulcerogenic potential of dihydroxy and trihydroxy bile acids in canine gastric mucosa.

Authors:  W P Ritchie; T S Felger
Journal:  Surgery       Date:  1981-03       Impact factor: 3.982

View more
  6 in total

1.  Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids.

Authors:  J Theisen; D Nehra; D Citron; J Johansson; J A Hagen; P F Crookes; S R DeMeester; C G Bremner; T R DeMeester; J H Peters
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

2.  Carcinogenic potential of duodenal reflux juice from patients with long-standing postgastrectomy.

Authors:  Z F Ma; Z Y Wang; J R Zhang; P Gong; H L Chen
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

3.  Protective effect of tauroursodeoxycholate against acute gastric mucosal injury induced by hydrophobic bile salts.

Authors:  M Muraca; E Zanusso; V Cianci; M T Vilei; P Pazzi; M Dalla Libera; S Gamberini
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

4.  Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity.

Authors:  D Nehra; P Howell; C P Williams; J K Pye; J Beynon
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

5.  Long-term follow-up after anti-reflux surgery in patients with Barrett's esophagus.

Authors:  Joerg Zehetner; Steven R DeMeester; Shahin Ayazi; Jesse L Costales; Florian Augustin; Arzu Oezcelik; John C Lipham; Helen J Sohn; Jeffrey A Hagen; Tom R DeMeester
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

Review 6.  Experimental evidence for mutagenic potential of duodenogastric juice on Barrett's esophagus.

Authors:  Joerg Theisen; Jeffrey H Peters; Hubert J Stein
Journal:  World J Surg       Date:  2003-07-17       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.